Missing the benefit of metformin in acute myeloid leukemia: A problem of contrast?

Missing the benefit of metformin in acute myeloid leukemia: A problem of contrast?

Objective: To evaluate whether metformin's cancer-related benefits reported in patients with solid tumors (ST) are also present in acute myeloid leukemia (AML) patients. Methods: Baseline demographic and clinical history for all diabetes mellitus patients newly diagnosed with AML or cancer of t...

Full description

Bibliographic Details
Main Authors: Alice C Ceacareanu, George K Nimako, Zachary A. P. Wintrob
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
Acute myeloid leukemia
disease-free survival
Metformin
overall survival
solid tumors
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2017;volume=6;issue=3;spage=145;epage=150;aulast=Ceacareanu

Internet

http://www.jrpp.net/article.asp?issn=2319-9644;year=2017;volume=6;issue=3;spage=145;epage=150;aulast=Ceacareanu

Similar Items